Elevated levels of expired breath hydrogen peroxide in bronchiectasis.

Airway inflammation is important in the development and progression of many lung diseases, including bronchiectasis. Activation of inflammatory cells such as neutrophils, eosinophils, and macrophages induces a respiratory burst resulting in the production of reactive oxygen species such as hydrogen peroxide (H2O2). We have measured exhaled H2O2 in patients with documented bronchiectasis and investigated whether the concentration of H2O2 is related to the disease severity, as defined by lung function. We also investigated whether the concentrations of expired H2O2 were different in bronchiectatic patients who received inhaled corticosteroids compared with steroid-naïve patients. In 37 patients with bronchiectasis (mean age, 45 +/- 2.5 yr; FEV1, 59 +/- 3% pred), mean H2O2 concentration in exhaled breath condensate was significantly elevated as compared with the values in 25 age-matched (mean age, 42 +/- 2 yr) normal subjects (0.87 +/- 0.01 versus 0.26 +/- 0.04 microM, p < 0.001). There was a significant negative correlation between H2O2 and FEV1 (r = -0.76, p < 0.0001). Patients treated with inhaled corticosteroids had values of H2O2 similar to those of steroid-naïve patients (0.8 +/- 0.1 versus 0.9 +/- 0.1, p > 0.05). We conclude that H2O2 is elevated in exhaled air condensate of patients with bronchiectasis and is correlated with disease severity. Measurement of H2O2 may be used as a simple noninvasive method to monitor airway inflammation and oxidative stress.

[1]  Q. Jöbsis,et al.  Hydrogen peroxide in exhaled air is increased in stable asthmatic children. , 1997, The European respiratory journal.

[2]  P. Barnes,et al.  Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. , 1997, American journal of respiratory and critical care medicine.

[3]  K. Aben,et al.  Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.

[4]  Levin Sj.  Bronchial epithelial cell-cytokine interactions in airway inflammation. , 1995 .

[5]  R. Sepper,et al.  Human neutrophil collagenase (MMP-8), identified in bronchiectasis BAL fluid, correlates with severity of disease. , 1995, Chest.

[6]  H. Lode,et al.  Cells and Cytokines in Chronic Bronchial Infection , 1994, Annals of the New York Academy of Sciences.

[7]  H. Black,et al.  Expired breath hydrogen peroxide is a marker of acute airway inflammation in pediatric patients with asthma. , 1993, The American review of respiratory disease.

[8]  I. Lauder,et al.  Multivariate analysis of factors affecting pulmonary function in bronchiectasis. , 1993, Respiration; international review of thoracic diseases.

[9]  J. Elborn,et al.  Inhaled steroids in patients with bronchiectasis. , 1992, Respiratory medicine.

[10]  B. Wallaert,et al.  Oxidants and bronchial inflammatory processes. , 1990, The European respiratory journal.

[11]  E. Bardana,et al.  Bronchiectasis: update of an orphan disease. , 1988, The American review of respiratory disease.

[12]  P. Henson,et al.  Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins. , 1987, The Journal of clinical investigation.

[13]  R. Simon,et al.  OXIDANT ACTIVITY IN EXPIRED BREATH OF PATIENTS WITH ADULT RESPIRATORY DISTRESS SYNDROME , 1986, The Lancet.